| Amanda Beth Womack, APRN | |
|
300 Garnet Way, Warm Springs, MT 59756-9700 | |
| (406) 693-7000 | |
| Not Available |
| Full Name | Amanda Beth Womack |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 300 Garnet Way, Warm Springs, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235794918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 136083 (Montana) | Primary |
| Entity Name | State Of Montana |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356351183 PECOS PAC ID: 3870499676 Enrollment ID: O20031211000579 |
News Archive
With a little practice on a computer or iPad-25 minutes a day, 4 days a week, for 2 months-our brains can learn to see better, according to a study of University of California, Riverside baseball players reported in the Cell Press journal Current Biology on February 17.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
JAFRA Cosmetics International, Inc., a leader in direct-sales, today announced it has donated a portion of product sales, totaling more than $100,000, to help SOS Children's Villages construct a new village in Vietnam. The donation is part of a larger gift to the SOS Children's Villages that was made by JAFRA parent company, the Vorwerk Group, a family-owned business based in Germany.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Beth Womack, APRN 300 Garnet Way, Warm Springs, MT 59756-9700 Ph: () - | Amanda Beth Womack, APRN 300 Garnet Way, Warm Springs, MT 59756-9700 Ph: (406) 693-7000 |
News Archive
With a little practice on a computer or iPad-25 minutes a day, 4 days a week, for 2 months-our brains can learn to see better, according to a study of University of California, Riverside baseball players reported in the Cell Press journal Current Biology on February 17.
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. announced today that they entered into a research collaboration agreement to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes. Researchers at The University of Texas (UT) Southwestern Medical Center will conduct the study.
JAFRA Cosmetics International, Inc., a leader in direct-sales, today announced it has donated a portion of product sales, totaling more than $100,000, to help SOS Children's Villages construct a new village in Vietnam. The donation is part of a larger gift to the SOS Children's Villages that was made by JAFRA parent company, the Vorwerk Group, a family-owned business based in Germany.
Cuts included in the spending bill approved by the U.S. House of Representatives this past week would harm seniors by drastically slashing initiatives that help older Americans to sustain their economic independence and health.
Repros Therapeutics Inc. today announced it has received written confirmation from the FDA noting the full clinical hold on Proellex® has been lifted. The Company will be allowed to run a single study under the new partial clinical hold status. The new low dose study is designed to explore both safety and signals of efficacy in an escalating dose fashion.
› Verified 6 days ago
Christine Marie Walsh, AGNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7000 Fax: 406-693-7267 | |
Melody S Wilkinson, AGPCNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7000 | |
Nora Ann Schillo, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7008 | |
Stephanie G Dever, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7000 | |
Kammiell Smith, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7008 Fax: 406-444-3082 | |
Cory Daniels, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 Garnet Way, Warm Springs, MT 59756 Phone: 406-693-7000 |